Novel Poly(Adenosine Diphosphate-Ribose) Polymerase (PARP) Inhibitor, AZD2461, Down-Regulates VEGF and Induces Apoptosis in Prostate Cancer Cells

BACKGROUND: Prostate cancer (Pca) is a heterogeneous disease, and current treatments are not based on molecular stratification. Poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors have recently been found to be remarkably toxic to cells with defects in homologous recombination, par...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Iran Biomed J
Glavni autori: Sargazi, Saman, Saravani, Ramin, Zavar Reza, Javad, Zarei Jaliani, Hossein, Galavi, Hamidreza, Moudi, Mahdiyeh, Alsadat Abtahi, Najmeh
Format: Artigo
Jezik:Inglês
Izdano: Pasteur Institute of Iran 2019
Teme:
Full Length
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6661129/
https://ncbi.nlm.nih.gov/pubmed/31102368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.29252/.23.5.312
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items